Journal of the Korean Ophthalmological Society 2006;47(4):571-576.
Published online April 30, 2006.
Ahmed Valve Implantation Result and TGF-beta and VEGF in the Aqueous Humor of Neovascular Glaucoma Patients.
Won Kyung Song, Jun Haeng Lee, Young Jae Hong, Chan Yun Kim
The Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Hospital, Seoul, Korea. kcyeye@yahoo.co.kr
신생혈관녹내장 환자의 방수내 변형성장인자-β와 혈관내피성장인자 농도와 아메드밸브 수술 결과
송원경,이준행,홍영재,김찬윤
The Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Hospital, Seoul, Korea
Correspondence:  Won Kyung Song, M.D.
Abstract
PURPOSE
To assess the relationship of transforming growth factor-beta (TGF-beta) and vascular endothelial growth factor (VEGF) levels in the aqueous humor of neovascular glaucoma (NVG) patients and the results of Ahmed valve implantation surgery. METHODS: We compared surgical outcomes of NVG patients who underwent Ahmed valve implant surgery from January 2002 through October 2002 at severance hospital with levels of TGF-beta1, TGF-beta2 and VEGF in the aqueous humors of these patients. RESULTS: Nineteen eyes (19 patients) were analyzed in the study. The success of surgery was defined as intraocular pressure maintained as 6-20 mm Hg regardless of additional glaucoma medications taken. Twelve eyes (63%) satisfied successful surgery. TGF-beta1 concentration was 1.51 ng/ml in the success group and 2.31 ng/ml in the failed group (p=0.295). TGF-beta2 concentration was 5.19 ng/ml in the success group and 5.73 ng/ml in the failed group (p=0.367). VEGF concentration was 10.21 ng/ml in the success group and 9.87 ng/ml in the failed group (p=0.516). All showed no statistical difference between the groups. CONCLUSIONS: In our study, no significant relationship between levels of TGF-beta1, TGF-beta2, or VEGF in the aqueous humor and the surgical outcomes of Ahmed valve implantation were found in patients with NVG.
Key Words: Ahmed valve;Neovascular glaucoma;Transforming growth factor-beta;Vascular endothelial growth factor


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next